Showing 841 - 860 results of 1,926 for search 'EPIHL~', query time: 2.59s Refine Results
  1. 841
  2. 842
  3. 843
  4. 844
  5. 845

    Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial by John Porter, Donald K. Bowden, Marina Economou, Jacques Troncy, Arnold Ganser, Dany Habr, Nicolas Martin, Adam Gater, Diana Rofail, Linda Abetz-Webb, Helen Lau, Maria Domenica Cappellini

    Published 2012-01-01
    “…The current article presents patient-reported HRQOL, satisfaction, adherence, and persistence data from β-thalassemia (n=274) and myelodysplastic syndrome (MDS) patients (n=168) patients participating in the Evaluation of Patients' Iron Chelation with Exjade (EPIC) study (NCT00171821); a large-scale 1-year, phase IIIb study investigating the efficacy and safety of the once-daily oral iron chelator, deferasirox. …”
    Get full text
    Article
  6. 846
  7. 847
  8. 848
  9. 849
  10. 850
  11. 851
  12. 852
  13. 853
  14. 854
  15. 855
  16. 856
  17. 857
  18. 858
  19. 859
  20. 860